{"id":"NCT00667602","sponsor":"Novartis Vaccines","briefTitle":"Safety and Immunogenicity Evaluation After One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants and Toddlers","officialTitle":"A Phase 3, Open-Label, Randomized, Multi-Center Study to Evaluate the Safety and Immunogenicity After One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine Administered to Healthy Infants and Toddlers","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-03","primaryCompletion":"2009-07","completion":"2010-10","firstPosted":"2008-04-28","resultsPosted":"2013-11-07","lastUpdate":"2013-11-07"},"enrollment":662,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Meningococcal Meningitis"],"interventions":[{"type":"BIOLOGICAL","name":"MenACWY-CRM197 (two doses)","otherNames":[]},{"type":"BIOLOGICAL","name":"MenC","otherNames":[]},{"type":"BIOLOGICAL","name":"PCV7","otherNames":[]},{"type":"BIOLOGICAL","name":"DTPa-IPV-HepB-Hib","otherNames":[]},{"type":"BIOLOGICAL","name":"MenACWY-CRM197 (one dose)","otherNames":[]}],"arms":[{"label":"MenACWY-CRM197 (2 doses) + Concomitant Vaccines","type":"EXPERIMENTAL"},{"label":"MenACWY-CRM197 (1 dose) + Concomitant Vaccines","type":"EXPERIMENTAL"},{"label":"MenC (1 dose) + Concomitant Vaccines","type":"ACTIVE_COMPARATOR"}],"summary":"The primary immunogenicity objective is to assess and compare the immunogenicity of one dose of MenACWY to one dose of Menjugate given to healthy toddlers at 12 months of age as measured by the percentage of subjects with serum bactericidal titers directed against N. meningitidis serogroup C ≥ 1:8 obtained in the serum bactericidal assay using human complement (hSBA).","primaryOutcome":{"measure":"Percentages of Subjects With Serum Bactericidal Titer ≥ 1:8 Against N.Meningitidis Serogroup C","timeFrame":"1 month postvaccination","effectByArm":[{"arm":"MenACWY-CRM197 (1dose) + Concomitant Vaccines","deltaMin":83,"sd":null},{"arm":"MenC (1dose) + Concomitant Vaccines","deltaMin":92,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"6 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":1,"exclusionCount":4},"locations":{"siteCount":28,"countries":["Germany"]},"refs":{"pmids":["33325757"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":13,"n":195},"commonTop":["Pyrexia","Injection site erythema","Somnolence","Injection site induration","Injection site pain"]}}